Scientist, PHD, MPH
Dr. Anita Ho is a bioethicist with a unique combined academic training and experience in clinical/organizational ethics, public health, business, and philosophy.
- Bioethics (clinical, organizational, public health, global health)
- Shared decision making
- End-of-life care
- Innovative health technologies
- Research ethics
- Health care access/disparity
- Opioid/pain management
In addition to being a Scientist at CHÉOS, Anita is currently an Associate Professor in bioethics and health services research at the Centre for Applied Ethics at the University of British Columbia, and an Associate Adjunct Professor in the Bioethics Program at the University of California, San Francisco.
Centre for Biomedical Ethics at the National University of Singapore School of Medicine between 2014 and 2017.
An international scholar and author of more than 60 publications, Anita’s current research focuses on supportive decision making for various chronic conditions (e.g., heart failure, chronic kidney diseases, cancers) and end-of-life care decisions. Her broader research areas include ethical dimensions of utilizing innovative and artificial intelligence technologies in health care, trust, and decision making in domestic and international clinical and research medicine, organizational and system ethics in medicine, cross-cultural and global health ethics, health-care resource allocation and disparity, professional-patient relationship, ethics education for health professionals, disability and pain experiences, and various concepts of autonomy. Anita is currently a Section Editor in research ethics for BMC Medical Ethics and an editorial board member for the International Journal of Feminist Approaches to Bioethics (IJFAB).
- Associate Professor, Centre for Applied Ethics, University of British Columbia
- Associate Adjunct Professor, Bioethics Program, University of California, San Francisco
- Unvaccinated: The implications of COVID-19 vaccine hesitancy (Vancouver Sun, June 2021)
- Prisons are covid hot spots. But few countries are prioritizing vaccines for inmates (The Washington Post, January 2021)
- ‘Grave risk:’ Advocates say inmates should get speedy access to COVID-19 vaccine (Yahoo! News, December 2020)